AzTrials
AzTrials

Ostomy - Ileostomy or ColostomyEarly Phase 1NCT07424586

Improving Outcomes of Older Adults Undergoing Ostomy Surgery

A Early Phase 1 study testing Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA) in people with Ostomy - Ileostomy or Colostomy, run by Massachusetts General Hospital at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this pilot study is to learn if an intervention in patients undergoing ostomy surgery is easy to use. The overall goal of the work is to improve quality of life during recovery in the days after surgery for these patients using the intervention. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ostomy - Ileostomy or Colostomy
What is being tested?
Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
11 Feb 2026to 30 Nov 2026
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients Age 65+ years
  • clinicians age 18+ years
  • Patients undergoing fecal ostomy surgery and their clinicians

Who cannot join

  • cognitive impairment not allowing completion of consent procedures based on the teach-back method.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christy Cauley, MD, MPH contact

617-726-8129

ccauley@mgb.org

Jana Zeineddine, MD contact

617-726-8129

ccauley@mgb.org

United States1 site, 1 recruiting
  • MassGeneral Hospital

    Boston, Massachusetts, 02114

    Christy Cauley, MD, MPH, 617-726-8129, ccauley@mgb.org

    Christy Cauley, MD, MPH

    Recruiting

Other trials in United States

About this study

Official title: Improving Biopsychosocial Outcomes of Older Adults Undergoing Fecal Ostomy Surgery

The goal of this pilot study is to learn if an intervention in patients undergoing ostomy surgery is easy to use. The overall goal of the work is to improve quality of life during recovery in the days after surgery for these patients using the intervention.

Read the detailed description

In this study the acceptability and usability of an intervention to evaluate and address biopsychosocial outcomes for older adults undergoing fecal ostomy surgery will be evaluated with the overall goal of improving patient-centered outcomes.

Being tested
Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA)
Keywords
ostomy, quality of life, biopsychosocial outcomes, web-based intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA)Behavioural

    The web-based intervention provides patients with a survey and tailored content with the purpose of better supporting recovery and adaptation after surgery with a fecal ostomy

Study groups in NCT07424586
Study groupRoleWhat they receive
GA-STOMAExperimentalA web-based intervention will be provided in addition to routine surgical care.
Receives: Behavioral: Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability

    Interviews will be performed to assess the ability to use the intervention, complete questions, obtain management recommendations and complete management recommendations.

    Measured: 6 weeks

Secondary outcomes (1)
  1. Client Satisfaction questionnaire

    This is a quantitative evaluation of intervention acceptability

    Measured: 6 weeks after surgery date

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2026
  2. Study start11 Feb 2026
  3. Primary completion1 Oct 2026 (estimated)
  4. Study completion30 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Open Pilot of patients and clinicians to assess web-based intervention acceptability and usability.
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07424586
Sponsor's protocol ID
2025P002770
Other IDs
K76AG088346
Status last verified
Jun 2026
First submitted
14 Feb 2026
Last updated
15 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA) in people with Ostomy - Ileostomy or Colostomy, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christy Cauley, MD, MPH (617-726-8129, ccauley@mgb.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in